Investigation of the mechanisms by which EB1089 abrogates apoptosis induced by 9-cis retinoic acid in pancreatic cancer cells

Pancreas

Volumn 32, Issue 1, 2006, Pages 93-100

  Mouratidis, Petros X E ^a   Dalgleish, Angus G ^a   Colston, Kay W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

9 cis RA; Apoptosis; EB1089; Pancreas; Retinoids; Vitamin D

Indexed keywords

ALITRETINOIN; BIM PROTEIN; CASPASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; SEOCALCITOL; TUMOR ANTIGEN; VITAMIN D DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 29144462481     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000191648.47667.4f     Document Type: Article

References (41)

1. National Cancer Institute. Pancreas cancer (invasive) survival rates 1975-2001SEER. Cancer statistics review (database online). Available at http://seer.cancer.gov/cgi-bin/csr/1975_2001/search.pl. Accessed July 10, 2004.
2. Arbuck SG. Overview of chemotherapy for pancreatic cancer. Int J Pancreatol. 1990;7:209-222.
3. Warsaw AL, Castillo CF. Pancreatic carcinoma. N Engl J Med. 1992;326:455-465.
4. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet. 1997;349:485-489.
5. Life Extension. Pancreatic cancer - disease therapies protocol Available at http://www.lef.org/protocols/prtcl-113.shtml. Accessed July 10, 2004.
6. Pettersson F, Colston KW, Dalgleish AG. Retinoic acid enhances the cytotoxic effects of Gemcitabine and Cisplatin in pancreatic adenocarcinoma cells. Pancreas. 2001;23:273-279.
7. Crouch RK, Chader GJ, Wiggert B, et al. Retinoids and the visual process. Photochem Photobiol. 1996;64:613-621.
8. Ross SA, McCaffery PJ, Drager UC, et al. Retinoids in embryonal development. Physiol Rev. 2000;80:1021-1054.
9. Rosewicz S, Stier U, Brembeck F, et al. Retinoids: effect on growth, differentiation and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology. 1995;109:1646-1660.
10. Simoni D, Tolomeo M. Retinoids, apoptosis and cancer. Curr Pharm Des. 2001;7:1823-1837.
11. Gottardis MM, Lamph WW, Shalinsky DR, et al. The efficacy of 9-cis retinoic acid in experimental models of cancer. Breast Cancer Res Treat. 1996;38:85-96.
12. Wald G. The molecular basis of visual excitation. Nature. 1968;219:800-807.
13. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signalling. Endocr Rev. 1994;15:61-79.
14. Napoli JL. Biochemical pathways of retinoid transport, metabolism and signal transduction. Clin Immunol Immunopathol. 1996;80:S52-S62.
15. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-cis Retinoic acid is a high affinity ligand for the retinoic X receptor. Cell. 1992;68:397-406.
16. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol. 1999;277:F157-F175.
17. Oades GM, Dredge K, Kirby RS, et al. Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer. BJU Int. 2002;90:607-616.
18. Jensen SS, Madsen MW, Lukas J, et al. Sensitivity to growth suppression by 1a,25-dihydroxyvitamin D3 among MCF-7 clones correlates with vitamin D receptor protein induction. J Steroid Biochem Molec Biol. 2002;81:123-133.
19. Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer. 2002;9:45-59.
20. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signalling. J Cell Biol. 2001;154:369-387.
21. Colston KW, James SY, Ofori-kuragu EA, et al. Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer. 1997;76:1017-1020.
22. Kawa S, Yoshizawa K, Tokoo M, et al. Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology. 1996;110:1605-1613.
23. Haussler MR, Haussler CA, Jurutka PW, et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. 1997;154(suppl):S57-S73.
24. Hansen CM, Maenpaa PH. EB1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells. Biochem Pharmacol. 1997;54:1173-1179.
25. Hansen CM, Hamberg KJ, Binderup E, et al. Seocalcitol (EB1089): a vitamin D analogue of anticancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr Pharm Des. 2000;6:803-828.
26. Pettersson F, Colston KW, Dalgleish AG. Differential and antagonistic effects of 9-cis retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro. Br J Cancer. 2000;83:239-245.
27. Zhou BP, Liao Y, Xia W, et al. Cytoplasmic localization of p21Cip1/Waf1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol. 2001;3:245-252.
28. kip1 expression. J Biol Chem. 2000;275:24500-24505.
29. Okabe T, Yamaguchi N, Ohsawa N. Establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the exocrine pancreas. Cancer. 1983;51:662-668.
30. Hirai H, Okabe T, Anraku Y, et al. Activation of the c-K-ras oncogene in a human pancreas carcinoma. Biochem Biophys Res Commun. 1985;127:168-174.
31. Pettersson F, Dalgleish AG, Bissonnette RP, et al. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-γ and altered expression of Bcl2/Bax. Br J Cancer. 2002;87:555-561.
32. Hsu SL, Hsu JW, Liu MC, et al. Retinoic acid mediated G1 arrest is associated with induction of p27kip1 and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Exp Cell Res. 2000;258:322-331.
33. Borriello A, Della Pietra V, Criscuolo M, et al. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation. Oncogene. 2000;19:51-60.
34. Kawa S, Nikaido T, Aoki Y, et al. Arotinoid mofarotene (RO40-8757) upregulates p21 and p27 during growth inhibition of pancreatic cancer cell lines. Int J Cancer. 1997;72:906-911.
35. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 2003;13:65-70.
36. Lloyd RV, Erickson LA, Jin L, et al. p27Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154:313-323.
37. El-Deiry WS. Akt takes centre stage in cell-cycle deregulation. Nat Cell Biol. 2001;3:E1-E3.
38. Testa JR, Bellacosa A. Akt plays a central role in tumorigenesis. Proc Natl Acad Sci USA. 2001;98:10983-10985.
39. El-Metwally TH, Pour PM, Kuszynski CA, et al. Differentiation is a prerequisite for apoptosis in pancreatic cancer cells treated with retinoids. Pancreas. 1998;17:432.
40. Frazier ML, Lilly BJ, Wu EF, et al. Carbonic anhydrase II gene expression in cell lines from human pancreatic adenocarcinoma. Pancreas. 1990;5:507-514.
41. Ding XZ, Kuszynski CA, El-Metwally TH, et al. Lipoxygenase inhibition induced apoptosis, morphological changes and carbonic anhydrase expression in human pancreatic cancer cells. Biochem Biophys Res Commun. 1999;266:392-399.